Package 11673-847-35

{"route": ["ORAL"], "spl_id": "35fedca9-3c7b-5252-e99f-a62f55564e69", "openfda": {"unii": ["SOD6A38AGA"], "rxcui": ["855172"], "spl_set_id": ["7e933c85-96b0-b103-e26a-1aa8a1ded58e"], "manufacturer_name": ["Target Corporation"]}, "finished": true, "packaging": [{"sample": false, "description": "2 BOTTLE in 1 CARTON (11673-847-16)  / 80 TABLET, COATED in 1 BOTTLE", "package_ndc": "11673-847-16", "marketing_start_date": "20201201"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (11673-847-35)  / 35 TABLET, COATED in 1 BOTTLE", "package_ndc": "11673-847-35", "marketing_start_date": "20181231"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (11673-847-80)  / 80 TABLET, COATED in 1 BOTTLE", "package_ndc": "11673-847-80", "marketing_start_date": "20181231"}], "brand_name": "levocetirizine dihydrochloride", "product_id": "11673-847_35fedca9-3c7b-5252-e99f-a62f55564e69", "dosage_form": "TABLET, COATED", "pharm_class": ["Histamine H1 Receptor Antagonists [MoA]", "Histamine-1 Receptor Antagonist [EPC]"], "product_ndc": "11673-847", "generic_name": "levocetirizine dihydrochloride", "labeler_name": "Target Corporation", "product_type": "HUMAN OTC DRUG", "brand_name_base": "levocetirizine dihydrochloride", "active_ingredients": [{"name": "LEVOCETIRIZINE DIHYDROCHLORIDE", "strength": "5 mg/1"}], "application_number": "ANDA210375", "marketing_category": "ANDA", "marketing_start_date": "20181231", "listing_expiration_date": "20271231"}